Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
23.71
-11.40
-48.08%
Share Warrants & Outstandings
Total Reserve
33.10
0.95
32.15
3,384.21%
Shareholder's Funds
45.42
24.65
20.77
84.26%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.00
2.38
0.00%
Secured Loans
2.38
0.00
2.38
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-4.37
0.00
-4.37
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
0.00
-1.87
0.00%
Current Liabilities
Trade Payables
5.59
0.00
5.59
0.00%
Other Current Liabilities
1.74
0.14
1.60
1,142.86%
Short Term Borrowings
5.02
0.44
4.58
1,040.91%
Short Term Provisions
0.01
0.00
0.01
0.00%
Total Current Liabilities
12.37
0.57
11.80
2,070.18%
Total Liabilities
55.92
25.23
30.69
121.64%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
0.05
27.13
54,260.00%
Less: Accumulated Depreciation
8.48
0.01
8.47
84,700.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
0.04
18.66
46,650.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.00
0.05
0.00%
Long Term Loans & Advances
2.12
0.02
2.10
10,500.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
31.01
0.07
30.94
44,200.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
0.00
8.22
0.00%
Sundry Debtors
13.54
0.60
12.94
2,156.67%
Cash and Bank
0.73
21.30
-20.57
-96.57%
Other Current Assets
0.41
0.00
0.41
0.00%
Short Term Loans and Advances
2.00
3.26
-1.26
-38.65%
Total Current Assets
24.91
25.16
-0.25
-0.99%
Net Current Assets (Including Current Investments)
12.54
24.59
-12.05
-49.00%
Total Current Assets Excluding Current Investments
24.91
25.16
-0.25
-0.99%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
25.23
30.69
121.64%
Contingent Liabilities
0.00
0.49
-0.49
-100.00%
Total Debt
7.40
0.44
6.96
1,581.82%
Book Value per share (adjusted)
7.38
10.40
-3.02
-29.04%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024






